
Talkie.ai is a healthcare-focused AI platform that automates medical practice phone systems with AI voice agents, improving patient access and reducing front desk workload. It offers solutions like appointment scheduling, prescription refills, call routing, and FAQ automation, integrated with major EHR systems such as athenahealth, ModMed, Epic, and Elation. The platform is HIPAA-compliant and SOC 2 Type II certified, serving multiple specialties including dermatology, OB-GYN, orthopedics, and primary care. Talkie.ai automates over half a million calls monthly, significantly reducing call center costs and on-hold times while increasing patient satisfaction and operational efficiency.

Talkie.ai is a healthcare-focused AI platform that automates medical practice phone systems with AI voice agents, improving patient access and reducing front desk workload. It offers solutions like appointment scheduling, prescription refills, call routing, and FAQ automation, integrated with major EHR systems such as athenahealth, ModMed, Epic, and Elation. The platform is HIPAA-compliant and SOC 2 Type II certified, serving multiple specialties including dermatology, OB-GYN, orthopedics, and primary care. Talkie.ai automates over half a million calls monthly, significantly reducing call center costs and on-hold times while increasing patient satisfaction and operational efficiency.
Sector: Healthcare conversational AI (AI phone agents / voicebots)
Core product: AI medical receptionists that handle calls, scheduling, Rx refills, FAQs, routing, and EHR logging
Compliance / security: HIPAA-compliant and SOC 2 Type II certified
Scale: Automates hundreds of thousands to over half a million calls monthly
Founded: 2018
Patient access and front-desk automation for medical practices
2018
Healthcare; Artificial Intelligence
Seed round announced July 22, 2022 with multiple participating investors
5210000.00 USD
Last funding date reported as 2024-08-01 and total funding reported as $5,210,000
“4growth VC and Movens Capital are listed among investors; multiple European VC funds and co-investors participated in the Seed round”